FDA Adverse Event Malfunction Summary report: N

ACCESS

MDR report key: 3973795 · Received August 1, 2014

Report

Report Number
1416980-2014-25124
Event Type
Malfunction
Date Received
August 1, 2014
Date of Event
July 8, 2014
Report Date
July 9, 2014
Manufacturer
BIEFFE MEDITAL MANUFACTURING S.A.R.L. TUNIS
Product Code
FPA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT AFTER THE CHEMOTHERAPY AGENT CAME IN CONTACT WITH THE PATIENT THE AFFECTED AREA WAS RINSED WITH A DECONTAMINATION WASHING OF AMUCHINA (SODIUM IPOCHLORIDE). A BATCH REVIEW WAS CONDUCTED AND THERE WERE NO DEVIATIONS FOUND RELATED TO THIS REPORTED CONDITION DURING THE MANUFACTURE OF THIS LOT. THE DEVICE WAS RECEIVED FOR EVALUATION. DURING VISUAL INSPECTION, THE TUBING WAS OBSERVED TO BE DISCONNECTED FROM THE MILLIPORE FILTER. THE REPORTED PROBLEM WAS VERIFIED. THE CAUSE OF THE PROBLEM WAS DUE TO A MANUFACTURING ISSUE. A CAPA HAS BEEN OPENED FOR THIS ISSUE. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT A MIRAFILTER ADMINISTRATION SET TUBING DISCONNECTED FROM THE DRIP CHAMBER. THIS OCCURRED DURING INFUSION OF PACLITAXEL. AFTER THE DISCONNECTION, THE DRUG SOLUTION DRIPPED ON THE PATIENT. THERE WAS NO PATIENT INJURY OR MEDICAL INTERVENTION. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
450273 ACCESS SET, ADMINISTRATION, INTRAVASCULAR FPA BIEFFE MEDITAL MANUFACTURING S.A.R.L. TUNIS 14A30V092

Patients

Seq Age Sex Outcome Treatment
1 TAXOL (PACLITAXEL)